Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034058 · ClinicalTrials.gov registry record · NA
Post Market Surveillance Study of the Wingspan Stent System
A NA study, sponsored by Stryker Neurovascular.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT02034058 is a NA study that has completed, run by Stryker Neurovascular. The registered enrollment target is 152 participants.
The verdict
NCT02034058, a NA study, has completed, sponsored by Stryker Neurovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.
Interventions
- DEVICE Wingspan Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02034058
The ClinicalTrials.gov registry entry for NCT02034058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Neurovascular, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wingspan Stent System is the first listed.
NCT02034058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02034058 about?
NCT02034058 is a clinical study titled "Post Market Surveillance Study of the Wingspan Stent System". The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.
What is the current status of trial NCT02034058?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2013-12. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02034058?
The interventions under investigation include: Wingspan Stent System (DEVICE).
Who is sponsoring clinical trial NCT02034058?
This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.